Table 3.

Trial status of individual patients.

Patient	Age	Sex	Cancer type	Trial statusa
1	65	F	Colon	Initiate
2	65	F	Melanoma	Not in a trial
3	65	F	Breast	Initiate
4	65	M	Prostate	Not in a trial
5	65	M	Prostate	Enrolled
6	66	F	Breast	Initiate
7	66	F	Pancreatic neuroendocrine	Not in a trial
8	66	M	Melanoma	Not in a trial
9	66	M	Prostate	Not in a trial
10	67	F	Breast	Enrolled
11	67	F	Kidney	Not in a trial
12	68	M	Prostate	Enrolled
13	68	M	Pancreatic	Not in a trial
14	68	M	Lung	Enrolled
15	68	F	Pancreatic	Not in a trial
16	68	M	Prostate	Not in a trial
17	69	M	Bladder	Not in a trial
18	69	M	Prostate	Not in a trial
19	70	M	Liver	Not in a trial
20	70	M	Melanoma	Not in a trial
21	70	F	Breast	Not in a trial
22	70	M	Prostate	Not in a trial
23	71	M	Colorectal	Not in a trial
24	71	F	Rectal	Not in a trial
25	71	M	Pancreatic	Not in a trial
26	71	M	Melanoma	Not in a trial
27	71	F	Melanoma	Not in a trial
28	71	M	Prostate	Not in a trial
29	72	F	Melanoma	Not in a trial
30	73	M	Esophageal	Initiate
31	74	M	Prostate	Not in a trial
32	75	F	Lung	Enrolled
33	75	M	Colon	Not in a trial
34	75	F	Breast	Not in a trial
35	78	F	Esophageal	Not in a trial
36	78	M	Leydig cell	Enrolled
37	78	M	Prostate	Enrolled
38	83	M	Prostate	Not in a trial
39	95	M	Prostate	Not in a trial

Initiate: Either (a) referred to a dedicated phase 1 clinic at either the Pacific or Midwest site or (b) reviewed the clinical trial consent form at the Midwest site but had not yet signed the consent form.

Enrolled: Signed the consent form.

Not in a trial: Did not initiate or enroll in a trial.

^aTrial Status.